Scott Turner

7.5k citations

122 papers · 4.8k indexed · 1 hit paper · h-index 39

Physiology top 2%
- Diet and metabolism studies 15
- Adipose Tissue and Metabolism 9
Endocrinology, Diabetes and Metabolism top 1%
Cell Biology top 2%
- Muscle metabolism and nutrition 12
Clinical Biochemistry top 2%
Cancer Research top 5%
Epidemiology
- Liver Disease Diagnosis and Treatment 19
Pulmonary and Respiratory Medicine
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 15
Surgery
- Cholesterol and Lipid Metabolism 13
Oncology
- Drug Transport and Resistance Mechanisms 8
Hepatology
- Liver physiology and pathology 7

Co-authors: Marc K. Hellerstein Richard A. Neese Carine Beysen Martin Decaris Jean‐Marc Schwarz Claire Emson M K Hellerstein Kelvin W. Li
Cited by: Physiology Endocrinology, Diabetes and Metabolism Cell Biology
Journals: American Journal of Physiology-Endocrinology and Metabolism (7 papers)Journal of Lipid Research (6 papers)Journal of Hepatology (5 papers)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Scott Turner

117 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Scott Turner

Since Specialization

Citations

This map shows the geographic impact of Scott Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Turner more than expected).

Fields of papers citing papers by Scott Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Turner. The network helps show where Scott Turner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Scott Turner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott Turner Line = papers co-authored together Scott Turner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Metabolic labeling kinetics of brain-derived 24S-hydroxycholesterol in blood in multiple sclerosis: Effects of treatment with the remyelinating antibody rHIgM22 Multiple Sclerosis Journal - Experimental Translational and Clinical ·Mahalakshmi Shankaran,Kelvin W. Li,Yu. E. Piontek,Asyraaf Qayyum Abd Samat,Mark Fitch,Luo Mei-ying,Edna Nyangau,Gordon I. Smith,Samuel Klein,A. H. Eisen,Scott Turner,Marc K. Hellerstein	2025	0
2	Dual αvβ6 and αvβ1 Inhibition over 12 Weeks Reduces Active Type I Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial American Journal of Respiratory and Critical Care Medicine ·Sydney B. Montesi,Gregory P. Cosgrove,Scott Turner,Iris Y. Zhou,Nikos Efthimiou,Е Т Жилякова,Ciprian Catana,Valeska Sandvoss,Jaap Kosse,Martin Decaris,Chris N. Barnes,Éric Lefebvre,Peter Caravan	2025	3
3	Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial American Journal of Respiratory and Critical Care Medicine ·Lisa Lancaster,Vincent Cottin,Murali Ramaswamy,Wim Wuyts,Gísli Jenkins,Mary Beth Scholand,Michael Kreuter,Claudia Valenzuela,Christopher J. Ryerson,Jonathan Goldin,Grace Hyun J. Kim,Marzena Jurek,Martin Decaris,Jaap Kosse,Scott Turner,Chris N. Barnes,Hardean E. Achneck,Gregory P. Cosgrove,Éric Lefebvre,Kevin R. Flaherty	2024	35
4	714 Phase 1a trial of PLN-101095, an integrin αvβ8 and αvβ1 inhibitor, as monotherapy and in combination with pembrolizumab, in treatment-resistant patients with advanced or metastatic solid tumors SHILAP Revista de lepidopterología ·Adil Daud,Chris N. Barnes,S. E. Owen,Scott Turner,Mario Sznol,Éric Lefebvre,Hardean E. Achneck	2023	1
5	Pharmacological Inhibitors of Integrin α _v β ₆ That Differentially Modulate Protein Conformation Are Similarly Effective at Inhibiting Transforming Growth Factor Beta (TGF-β) Signaling in the Fibrotic Lung Erine H. Budi,Eleonora A.A. Dei-Cas,Kamal Jaafar,Vikram Rao,龍太郎笠井,L. Enachescu,Johanna Schaub,Scott Turner,Martin Decaris	2022	0
6	PLN-74809, A Dual α _V β ₆ /α _V β ₁ , Oral, Selective Integrin Inhibitor, Is Well Tolerated and Reduces Lung TGF-β Activity in Healthy Volunteers Eduard Gorina,Martin Decaris,Scott Turner,毛羽飞,Savio W.H. Wong,Ruse Bianto,Paul Segnitz,Katerina Leftheris,Éric Lefebvre	2020	2
7	Beta cell secretion of miR-375 to HDL is inversely associated with insulin secretion Scientific Reports ·Murad Ahmadov,Carine Beysen,Barbara Leicht,Danielle L. Michell,Quanhu Sheng,Shilin Zhao,Scott Turner,MacRae F. Linton,Kasey C. Vickers	2019	35
8	Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice Hepatology Communications ·Martine C. Morrison,Lars Verschuren,Kanita Salic,Joanne Verheij,Aswin Menke,Peter Y. Wielinga,Marta Iruarrizaga‐Lejarreta,Laurent Golé,Weimiao Yu,Scott Turner,Martien P. M. Caspers,Ibon Martínez‐Arranz,Elsbet Pieterman,Reinout Stoop,Arianne van Koppen,Anita M. van den Hoek,José M. Mato,Roeland Hanemaaijer,Cristina Alonso,Robert Kleemann	2018	53
9	Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib JCI Insight ·Jan A. Burger,Kelvin W. Li,Michael J. Keating,Mariela Sivina,Ahmed M. Amer,Naveen Garg,Alessandra Ferrajoli,Xuelin Huang,Hagop Kantarjian,William G. Wierda,Susan O’Brien,Marc K. Hellerstein,Scott Turner,Claire Emson,Shih‐Shih Chen,Xiao‐Jie Yan,Dominik Wodarz,Nicholas Chiorazzi	2017	69
10	Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice Cellular and Molecular Gastroenterology and Hepatology ·Caroline C. Duwaerts,Beck Jensen,高太郎北脇,Arthur Muirhead Howard,Mark Fitch,Carine Beysen,Scott Turner,Amanda Goodsell,Jody L. Baron,James P. Grenert,Soo‐Jin Cho,Jacquelyn J. Maher	2017	16
11	Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia Leukemia ·Elizabeth J. Murphy,Donna Neuberg,Laura Z. Rassenti,Gregory M. Hayes,Robert Redd,Claire Emson,Chi Kong Li,Jennifer R. Brown,William G. Wierda,Scott Turner,نسيمة شمام,Clive S. Zent,John C. Byrd,Burke Cartwright,Jacqueline C. Barrientos,Neil E. Kay,Marc K. Hellerstein,Nicholas Chiorazzi,Thomas J. Kipps,Jeimy Liliana Chávez Wong	2017	26
12	Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin Journal of Lipid Research ·Nuntakorn Thongtang,Margaret R. Diffenderfer,Esther Ooi,P. Hugh R. Barrett,Scott Turner,Ngoc‐Anh Le,W. Virgil Brown,Ernst J. Schaefer	2017	44
13	Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury The Journal of Nutritional Biochemistry ·Andrew A. Pierce,Caroline C. Duwaerts,金澤信幸,高太郎北脇,James P. Grenert,Mark Fitch,Marc K. Hellerstein,Carine Beysen,Scott Turner,Jacquelyn J. Maher	2015	16
14	In vivo Tissue Cholesterol Efflux is Impaired in Carriers of Mutations in APOA1 and ABCA1 Circulation ·Adriaan G. Holleboom,Remco Franssen,Lily Jakulj,名取多嘉雄,Menno Vergeer,Joris Koetsveld,Marc K. Hellerstein,John J.P. Kastelein,Albert K. Groen,Scott Turner,Erik S.G. Stroes	2010	1
15	Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with Prednisolone Journal of Pharmacology and Experimental Therapeutics ·Anni Juhlin,Krista A Varady,Scott Turner,Claire Emson,Richard W. Gelling,Mahalakshmi Shankaran,Glen Lindwall,Lauren E. Shipp,Thomas S. Scanlan,Jen-Chywan Wang,Marc K. Hellerstein	2010	11
16	Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions American Journal of Physiology-Gastrointestinal and Liver Physiology ·James L. Gardner,Scott Turner,Abraham P. Bautista,Glen Lindwall,Mohamad Awada,Marc K. Hellerstein	2007	33
17	Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 Journal of Lipid Research ·松永幸宏,Lorenzo Arnaboldi,Bernaldo Montaño,Jim Yan,Emanuel Alexandi,Ray Kit Ng,Scott Turner,Thomas M. Badger,Robert E. Pitas,Jacquelyn J. Maher	2006	219
18	In Vivo Measurement of Microtubule Dynamics Using Stable Isotope Labeling with Heavy Water Journal of Biological Chemistry ·Patrizia Fanara,Scott Turner,Robert Busch,Salena Killion,Mohamad Awada,Holly Turner,Ablatt Mahsut,Tze Wei Lim,Setareh Masoumi Mayni,Marc K. Hellerstein	2004	23
19	Measurement of TG synthesis and turnover in vivo by²H₂O incorporation into the glycerol moiety and application of MIDA American Journal of Physiology-Endocrinology and Metabolism ·Scott Turner,Elizabeth J. Murphy,Richard A. Neese,Marco Vallada Lemonte,Tiffany Thomas,Anil K. Agarwal,Emily Dunbar,Marc K. Hellerstein	2003	111
20	Global Civil Society, Anarchy and Governance: Assessing an Emerging Paradigm Journal of Peace Research ·Scott Turner	1998	34

About Scott Turner

Scott Turner is a scholar working on Hepatology, Cell Biology, Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Pharmaceutical Science, having authored 122 papers that have together received 4.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Diet and metabolism studies (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Cholesterol and Lipid Metabolism (13 papers), Muscle metabolism and nutrition (12 papers), Adipose Tissue and Metabolism (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Liver physiology and pathology (7 papers). The work is most often cited by research in Physiology (1.3k citations), Endocrinology, Diabetes and Metabolism (784 citations), Cell Biology (675 citations), Clinical Biochemistry (223 citations) and Cancer Research (416 citations). Scott Turner has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Marc K. Hellerstein, Richard A. Neese, Carine Beysen, Martin Decaris, Jean‐Marc Schwarz, Claire Emson, M K Hellerstein, Kelvin W. Li, Elizabeth J. Murphy and Mads Christiansen. Their work appears in journals such as American Journal of Physiology-Endocrinology and Metabolism, Journal of Lipid Research, Journal of Hepatology, Journal of Clinical Investigation and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact